Related references
Note: Only part of the references are listed.Glutamate-rich protein (GLURP) induces antibodies that inhibit in vitro growth of Plasmodium falciparum in a phase 1 malaria vaccine trial
Cornelus C. Hermsen et al.
VACCINE (2007)
Adjuvant activity of polymer microparticles and Montanide ISA 720 on immune responses to Plasmodium falciparum MSP2 long synthetic peptides in mice
E. Mata et al.
VACCINE (2007)
Vigorous hepatitis C virus-specific CD4+ and CD8+ T cell responses induced by protein immunization in the presence of montanide ISA720 plus synthetic oligodeoxynucleotides containing immunostimulatory cytosine-guanine dinucleotide motifs
F Sugauchi et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Influence of adjuvant formulation on the induced protection of mice immunized with total soluble antigen of Trichinella spiralis
S Deville et al.
VETERINARY PARASITOLOGY (2005)
The global distribution of clinical episodes of Plasmodium falciparum malaria
RW Snow et al.
NATURE (2005)
Mouse strain-dependent differences in enhancement of immune responses by C3d
FR Toapanta et al.
VACCINE (2004)
Potent, long lasting systemic antibody levels and mixed Th1/Th2 immune response after nasal immunization with malaria antigen loaded PLGA microparticles
AM Carcaboso et al.
VACCINE (2004)
Evaluation of immune responses elicited in mice against a recombinant malaria vaccine based on Plasmodium vivax Duffy binding protein
SS Yazdani et al.
VACCINE (2004)
Enhancing immunogenicity and reducing dose of microparticulated synthetic vaccines: Single intradermal administration
AM Carcaboso et al.
PHARMACEUTICAL RESEARCH (2004)
Safety and immunogenicity of a three-component blood-stage malaria vaccine (MSP1, MSP2, RESA) against Plasmodium falciparum in Papua New Guinean children
B Genton et al.
VACCINE (2003)
Vaccine adjuvants: role and mechanisms of action in vaccine immunogenicity
DJ Marciani
DRUG DISCOVERY TODAY (2003)
Immune response after oral administration of the encapsulated malaria synthetic peptide SPf66
AM Carcaboso et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2003)
Encapsulation of peptides in biodegradable microspheres prolongs their MHC class-I presentation by dendritic cells and macrophages in vitro
R Audran et al.
VACCINE (2003)
Uptake of poly(D,L-lactic-co-glycolic acid) microspheres by antigen-presenting cells in vivo
KD Newman et al.
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH (2002)
Remarkably high antibody levels and protection against P-falciparum malaria in Aotus monkeys after a single immunisation of SPf66 encapsulated in PLGA microspheres
JE Rosas et al.
VACCINE (2002)
Progress and challenges for malaria vaccines
TL Richie et al.
NATURE (2002)
Biodegradable PLGA microspheres as a delivery system for malaria synthetic peptide SPf66
JE Rosas et al.
VACCINE (2001)
Encapsulation in biodegradable microparticles enhances serum antibody response to parenterally-delivered β-amyloid in mice
DJ Brayden et al.
VACCINE (2001)
Induction of a cytotoxic T-cell response to HIV-1 proteins with short synthetic peptides and human compatible adjuvants
K Peter et al.
VACCINE (2001)
A phase I clinical trial of a mufti-epitope polypeptide TAB9 combined with Montanide ISA 720 adjuvant in non-HIV-1 infected human volunteers
H Toledo et al.
VACCINE (2001)
Defined synthetic vaccines
W Zauner et al.
BIOLOGICAL CHEMISTRY (2001)
Strain-dependent antibody response induced by DNA immunization
K Ito et al.
IMMUNOLOGY LETTERS (2000)
Protection against Plasmodium falciparum malaria in chimpanzees by immunization with the conserved preerythrocytic liver-stage antigen 3
P Daubersies et al.
NATURE MEDICINE (2000)
Protein instability in poly(lactic-co-glycolic acid) microparticles
M van de Weert et al.
PHARMACEUTICAL RESEARCH (2000)
Revisiting PLA/PLGA microspheres: an analysis of their potential in parenteral vaccination
P Johansen et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2000)
High immunogenicity in chimpanzees of peptides and lipopeptides derived from four new Plasmodium falciparum pre-erythrocytic molecules
L Benmohamed et al.
VACCINE (2000)
An investigation of the intradermal route as an effective means of immunization for microparticulate vaccine delivery systems
N Puri et al.
VACCINE (2000)
Cutaneous vaccination: the skin as an immunologically active tissue and the challenge of antigen delivery
S Babiuk et al.
JOURNAL OF CONTROLLED RELEASE (2000)
Naturally acquired antibodies to the glutamate-rich protein are associated with protection against Plasmodium falciparum malaria
D Dodoo et al.
JOURNAL OF INFECTIOUS DISEASES (2000)